Simulations Plus (SLP) Downgraded by BidaskClub to Hold

BidaskClub lowered shares of Simulations Plus (NASDAQ:SLP) from a buy rating to a hold rating in a report published on Thursday morning.

Separately, Zacks Investment Research upgraded Simulations Plus from a sell rating to a hold rating in a research note on Wednesday, January 24th.

Shares of Simulations Plus (NASDAQ SLP) traded up $0.50 during trading on Thursday, hitting $16.40. The stock had a trading volume of 46,900 shares, compared to its average volume of 51,722. The stock has a market capitalization of $274.95, a price-to-earnings ratio of 46.86 and a beta of -0.74. Simulations Plus has a 1 year low of $9.45 and a 1 year high of $17.45.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Tuesday, January 9th. The technology company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.09 by $0.01. The firm had revenue of $7.07 million for the quarter, compared to analyst estimates of $6.57 million. Simulations Plus had a return on equity of 24.56% and a net margin of 23.78%. equities analysts forecast that Simulations Plus will post 0.4 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, February 2nd. Shareholders of record on Friday, January 26th were paid a $0.06 dividend. The ex-dividend date was Thursday, January 25th. This represents a $0.24 annualized dividend and a yield of 1.46%. Simulations Plus’s dividend payout ratio (DPR) is presently 68.57%.

In other Simulations Plus news, Chairman Walter S. Woltosz sold 18,500 shares of Simulations Plus stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $16.25, for a total value of $300,625.00. Following the transaction, the chairman now owns 5,502,416 shares in the company, valued at $89,414,260. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold 55,500 shares of company stock worth $893,180 in the last quarter. 33.45% of the stock is owned by insiders.

Hedge funds have recently modified their holdings of the company. Macquarie Group Ltd. purchased a new stake in shares of Simulations Plus during the third quarter worth about $315,000. Northern Trust Corp lifted its holdings in shares of Simulations Plus by 248.7% during the second quarter. Northern Trust Corp now owns 145,018 shares of the technology company’s stock worth $1,791,000 after purchasing an additional 103,435 shares during the period. GSA Capital Partners LLP lifted its holdings in shares of Simulations Plus by 118.7% during the third quarter. GSA Capital Partners LLP now owns 47,110 shares of the technology company’s stock worth $730,000 after purchasing an additional 25,571 shares during the period. Bessemer Group Inc. lifted its holdings in shares of Simulations Plus by 285.7% during the third quarter. Bessemer Group Inc. now owns 29,700 shares of the technology company’s stock worth $460,000 after purchasing an additional 22,000 shares during the period. Finally, Wedge Capital Management L L P NC acquired a new stake in shares of Simulations Plus during the third quarter worth about $730,000. Institutional investors and hedge funds own 33.58% of the company’s stock.

WARNING: “Simulations Plus (SLP) Downgraded by BidaskClub to Hold” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/02/16/simulations-plus-slp-downgraded-by-bidaskclub-to-hold.html.

About Simulations Plus

Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply